RUO‘ZENLog in
Stocks › Healthcare › TAK

Takeda Pharmaceutical stockTAK

Takeda Pharmaceutical Co ADR · NYSE
$21.19
+0.62% on the day
close Nov 5, 2026
What is happening with the stock

Takeda Pharmaceutical trades at $21.19, 2.5% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +35.9% year to date, +55.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Jan 28, 2027.

Closing price, 6 monthsdetailed chart in the terminal
14.7318.3421.9452-week high 21.73May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for TAK — after you log in

Open the terminal
From 52-week high−2.5%
High21.73 Nov 5, 2026
vs 50-day avg+11.2%
vs 200-day avg+20.1%
Year to date+35.9%
12 months+55.9%
P/E27.5
Dividend yield2.57%
EarningsJan 28
Market cap$67.7B
Chart patterncup with handle
Exchange · sinceNYSE

Frequently asked questions about Takeda Pharmaceutical

What is the Takeda Pharmaceutical stock price?

At the close on Nov 5, 2026: $21.19 (+0.62% on the day). 52-week high: $21.73 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Takeda Pharmaceutical report earnings?

The next quarterly report is on Jan 28, 2027. Last quarter, earnings per share changed +163% year over year, revenue +6%.

Does Takeda Pharmaceutical pay dividends?

Yes, the dividend yield is about 2.57% a year.

Where does Takeda Pharmaceutical trade and how to buy it?

Ticker TAK, exchange NYSE. You can buy it through a broker with access to US exchanges.

Should I buy Takeda Pharmaceutical now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for TAK are in the terminal after you log in.

Similar stocks

More on TAK

Included in lists